{"id":3106,"date":"2021-09-21T08:45:37","date_gmt":"2021-09-21T08:45:37","guid":{"rendered":"https:\/\/atryshealth.com\/?post_type=articulo&#038;p=3106"},"modified":"2021-09-21T08:47:34","modified_gmt":"2021-09-21T08:47:34","slug":"molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2","status":"publish","type":"articulo","link":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/","title":{"rendered":"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer"},"content":{"rendered":"\n<p>Pere Puig , Nadina Erill, Marta Terricabras, Isaac Subirana, Judit Gonz\u00e1lez\u2011Garc\u00eda, Adri\u00e0 Asensi\u2011Puig, Michael J. Donovan, Lourdes Mengual, M. Teresa Agull\u00f3\u2011Ortu\u00f1o, Mireia Olivan, Antonio Alcaraz, Jos\u00e9 A. L\u00f3pez\u2011Mart\u00edn, In\u00e9s de Torres, Jos\u00e9 Luis Rodr\u00edguez\u2011Peralto, Alfredo Rodr\u00edguez\u2011Antol\u00edn, Juan Morote and V\u00edctor Gonz\u00e1lez\u2011Rumayor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pere Puig , Nadina Erill, Marta Terricabras, Isaac Subirana, Judit Gonz\u00e1lez\u2011Garc\u00eda, Adri\u00e0 Asensi\u2011Puig, Michael J. Donovan, Lourdes Mengual, M. Teresa Agull\u00f3\u2011Ortu\u00f1o, Mireia Olivan, Antonio Alcaraz, Jos\u00e9 A. L\u00f3pez\u2011Mart\u00edn, In\u00e9s de Torres, Jos\u00e9 Luis Rodr\u00edguez\u2011Peralto, Alfredo Rodr\u00edguez\u2011Antol\u00edn, Juan Morote and V\u00edctor Gonz\u00e1lez\u2011Rumayor.<\/p>\n","protected":false},"template":"","class_list":["post-3106","articulo","type-articulo","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer - Atrys Health<\/title>\n<meta name=\"description\" content=\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer - Atrys Health\" \/>\n<meta property=\"og:description\" content=\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Atrys Health\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-21T08:47:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1563\" \/>\n\t<meta property=\"og:image:height\" content=\"1014\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Atrys_Health\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\\\/\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\\\/\",\"name\":\"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer - Atrys Health\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#website\"},\"datePublished\":\"2021-09-21T08:45:37+00:00\",\"dateModified\":\"2021-09-21T08:47:34+00:00\",\"description\":\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Art\u00edculos y patentes\",\"item\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\",\"name\":\"Atrys Health\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#organization\",\"name\":\"Atrys Health S.A.\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/atrys-logo-probar-web.png\",\"contentUrl\":\"https:\\\/\\\/www.atryshealth.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/atrys-logo-probar-web.png\",\"width\":1563,\"height\":1014,\"caption\":\"Atrys Health S.A.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Atrys_Health\",\"https:\\\/\\\/es.linkedin.com\\\/company\\\/atrys-health\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCejhA_ghBXRG1xoe9HB9pEw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer - Atrys Health","description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/","og_locale":"es_ES","og_type":"article","og_title":"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer - Atrys Health","og_description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","og_url":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/","og_site_name":"Atrys Health","article_modified_time":"2021-09-21T08:47:34+00:00","og_image":[{"width":1563,"height":1014,"url":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Atrys_Health","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/","url":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/","name":"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer - Atrys Health","isPartOf":{"@id":"https:\/\/www.atryshealth.com\/es\/#website"},"datePublished":"2021-09-21T08:45:37+00:00","dateModified":"2021-09-21T08:47:34+00:00","description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","breadcrumb":{"@id":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.atryshealth.com\/es\/articulo\/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.atryshealth.com\/es\/"},{"@type":"ListItem","position":2,"name":"Art\u00edculos y patentes","item":"https:\/\/www.atryshealth.com\/es\/articulo\/"},{"@type":"ListItem","position":3,"name":"Multiple immunofluorescence assay identifies upregulation of Active \u03b2\u2011catenin in prostate cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.atryshealth.com\/es\/#website","url":"https:\/\/www.atryshealth.com\/es\/","name":"Atrys Health","description":"","publisher":{"@id":"https:\/\/www.atryshealth.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.atryshealth.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.atryshealth.com\/es\/#organization","name":"Atrys Health S.A.","url":"https:\/\/www.atryshealth.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.atryshealth.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","contentUrl":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","width":1563,"height":1014,"caption":"Atrys Health S.A."},"image":{"@id":"https:\/\/www.atryshealth.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Atrys_Health","https:\/\/es.linkedin.com\/company\/atrys-health","https:\/\/www.youtube.com\/channel\/UCejhA_ghBXRG1xoe9HB9pEw"]}]}},"_links":{"self":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/articulo\/3106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/articulo"}],"about":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/types\/articulo"}],"wp:attachment":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/media?parent=3106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}